Compounds > fludarabine

fludarabine and Anemia, Fanconi

fludarabine has been researched along with Anemia, Fanconi in 45 studies

Research

Studies (45)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (2.22)18.2507
2000's17 (37.78)29.6817
2010's24 (53.33)24.3611
2020's3 (6.67)2.80

Authors

AuthorsStudies
Keck, JL; Manthei, KA; Voter, AF1
Chen, J; Hu, S; Huang, X; Jiang, E; Jiang, H; Lan, M; Li, C; Li, F; Lin, F; Liu, S; Lu, P; Lu, Y; Luo, C; Sun, S; Sun, Y; Tang, Y; Wan, D; Wang, S; Wu, X; Xu, L; Xu, Y1
Abujoub, R; Alafghani, S; Aldaama, S; Almanjomi, F; Alsudairy, R; Alsultan, A; Ballourah, W; Essa, MF; Jarrar, MS; Memon, S1
Demsky, C; Gorfinkel, L; Kupfer, G; Pashankar, F; Shah, NC1
Abraham, A; Balasubramanian, P; Edison, ES; Fouzia, NA; George, B; Korula, A; Lakshmi, KM; Mathews, V; Mohanan, E; Panetta, JC; Srivastava, A; Viswabandya, A1
Han, TT; Huang, XJ; Mo, XD; Sun, YQ; Tang, FF; Wang, JZ; Wang, WJ; Xu, LP; Zhang, XH1
Al-Agil, A; Al-Ahmari, A; Al-Seraihi, A; Ayas, M; Ayas, MF; Ghemlas, I1
Al-Ahmari, A; Al-Jefri, A; Al-Saedi, H; Al-Seraihi, A; Alanazi, A; Ayas, M; Ayas, MF; Ghemlas, I; Jafri, R; Siddiqui, K1
Bertaina, A; Brescia, L; Comoli, P; Corbella, F; Giorgiani, G; Locatelli, F; Pagliara, D; Perotti, C; Strocchio, L; Zecca, M1
Al-Ahmari, A; Al-Jefri, A; Al-Musa, A; Al-Seraihy, A; Ayas, M; El-Solh, H; Khairy, A; Markiz, S; Shahin, H; Siddiqui, K1
Chang, TY; Chen, SH; Hsueh, C; Hung, IJ; Jaing, TH; Yang, CP1
Baker, KS; Burroughs, LM; Deeg, HJ; Delaney, C; Domm, J; Englund, JA; Flowers, ME; Giller, RH; Nemecek, ER; Rawlings, DJ; Shimamura, A; Skoda-Smith, S; Storb, R; Storer, BE; Talano, JA; Thakar, MS; Torgerson, TR; Woolfrey, AE1
Benajiba, L; Dalle, JH; Galambrun, C; Jubert, C; Peffault de Latour, R; Salvado, C; Socié, G; Soulier, J1
Blazar, BR; DeFor, TE; Dusenbery, KE; MacMillan, ML; Slungaard, A; Wagner, JE; Weisdorf, DJ; Young, JA; Zierhut, H1
Aytaç Eyüboğlu, S; Bayhan, T; Çetin, M; Gümrük, F; Kuşkonmaz, B; Tavil, B; Uçkan Çetinkaya, D; Ünal, Ş1
Chen, J; Ding, L; Li, B; Li, Q; Luo, C; Wang, J1
Akiyama, K; Aoki, T; Arakawa, Y; Hanada, R; Ikeda, Y; Koh, K; Mori, M; Sekinaka, Y1
Baker, KS; Boulad, F; Davies, SM; Guinan, E; Kernan, NA; Lane, A; Leemhuis, T; Lehmann, L; Margolis, D; Mehta, PA; Myers, K; O'Reilly, RJ; Prockop, SE; Scaradavou, A; Williams, DA1
Baker, JM; Crooks, BN; Doyle, JJ; Dror, Y; Duval, M; Fernandez, CV; Freedman, MH; Lewis, VA; Yuille, K1
Hazar, V; Karasu, GT; Kupesiz, A; Uygun, V; Yesilipek, MA1
Al-Mojalli, H; Ashour, M; Ayas, M; Turkistani, W1
Akiba, T; Hyodo, H; Ishiguro, H; Kato, S; Koike, T; Morimoto, T; Shimizu, T; Yabe, H; Yabe, M1
Flowers, ME; Frangoul, H; Kiem, HP; Kletzel, M; Kurre, P; Leisenring, W; Pulsipher, MA; Sandmaier, BM; Storb, R; Thakar, MS; Woolfrey, A1
Balashov, D; Brooks, R; Maschan, A; Or, R; Resnick, IB; Revel-Vilk, S; Rheingold, L; Shapira, MY; Skorobogatova, E; Stein, J; Stepensky, P; Trakhtman, P; Weintraub, M1
Al-Ahmari, A; Al-Jefri, A; Al-Seraihi, A; Aldali, A; Ayas, M; El-Solh, H; Khairy, A; Markiz, S; Siddiqui, K1
Alimoghaddam, K; Bahar, B; Behfar, M; Ghavamzadeh, A; Hamidieh, AA; Iravani, M; Jahani, M; Jalali, A; Jalili, M; Mousavi, SA1
Asami, K; Kato, S; Koike, T; Morimoto, T; Muroi, K; Oshima, K; Shimizu, T; Takakura, H; Takata, M; Tsukamoto, H; Yabe, H; Yabe, M; Yamashita, T1
Ehlert, K; Fruehwald, MC; Groll, AH; Juergens, H; Rossig, C1
Bonfim, C; Deeg, HJ; Flowers, ME; Gooley, T; Kiem, HP; O'Donnell, P; Pasquini, R; Ribeiro, L; Sandmaier, BM; Storb, R; Thakar, MS; Woolfrey, AE1
Comoli, P; De Stefano, P; Giorgiani, G; Locatelli, F; Maccario, R; Nobili, B; Rossi, G; Salvaneschi, L1
de la Fuente, J; Dokal, I; McCloy, M; Rahemtulla, A; Reiss, S; Roberts, IA; Vulliamy, T1
Balashov, DN; Dyshlevaja, ZM; Maschan, AA; Rumiantsev, AG; Samochatova, EV; Shipicina, IP; Skorobogatova, EV; Skvortsova, YV; Trakhtman, PE1
Auerbach, AD; Defor, TE; Macmillan, ML; Slungaard, A; Tan, PL; Wagner, JE1
Ackerstein, A; Aker, M; Bitan, M; Elad, S; Or, R; Resnick, IB; Samuel, S; Shapira, MY; Slavin, S1
Adachi, S; Hamanoue, S; Inoue, H; Ishiguro, H; Kato, S; Koike, H; Koike, K; Koike, T; Kojima, S; Matsumoto, M; Mori, T; Morimoto, A; Sako, M; Suzuki, K; Tsuchida, M; Tsuji, K; Yabe, H; Yabe, M1
Arakawa, S; Hamanoue, S; Inoue, H; Ishiguro, H; Katob, S; Koike, T; Masukawa, A; Matsumoto, M; Miyachi, H; Morimoto, T; Ohshima, T; Yabe, H; Yabe, M; Yamashita, T1
Bierings, M; Bittencourt, M; Bonfim, C; Champagne, MA; Darbyshire, P; Fernandez, MN; Gluckman, E; Harris, RE; Ionescu, I; Kurtzberg, J; Locatelli, F; Pasquini, R; Rocha, V; Wagner, J1
Akdemir, Y; Arpaci, F; Balci, YI; Cetin, M; Gumruk, F; Uckan, D1
Bernardo, ME; Di Bartolomeo, P; Fagioli, F; Locatelli, F; Longoni, D; Messina, C; Morreale, G; Nobili, B; Pession, A; Porta, F; Zecca, M1
Auerbach, AD; Boulad, F; Chaudhury, S; Heller, G; Kernan, NA; O'Reilly, RJ; Prockop, SE; Scaradavou, A; Small, TN; Wolden, S1
Bierings, MB; Heitink-Pollé, KM; Lilien, MR1
Kapelushnik, J; Nagler, A; Or, R; Slavin, S1
Auerbach, AD; Boulad, F; Collins, N; George, D; Gillio, A; Kernan, NA; O'Reilly, RJ; Prasad, V; Regan, AD; Small, TN; Torok-Castanza, J1
Almeida, A; Daly, P; Dokal, I; McCloy, M; Roberts, IA; Vulliamy, T1
de Medeiros, CR; Pasquini, R; Silva, LM1

Reviews

2 review(s) available for fludarabine and Anemia, Fanconi

ArticleYear
Late graft failure in FA--case report and review of the literature.
    Pediatric transplantation, 2012, Volume: 16, Issue:8

    Topics: Antigens, CD34; Antineoplastic Agents; Child; Fanconi Anemia; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Neutrophils; Risk Factors; Thrombocytopenia; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2012
Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
    British journal of haematology, 2008, Volume: 140, Issue:6

    Topics: Adolescent; Adult; Child; Child, Preschool; Fanconi Anemia; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Lymphocyte Depletion; Male; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Treatment Outcome; Vidarabine

2008

Trials

8 trial(s) available for fludarabine and Anemia, Fanconi

ArticleYear
Successful Outcome in Patients with Fanconi Anemia Undergoing T Cell-Replete Mismatched Related Donor Hematopoietic Cell Transplantation Using Reduced-Dose Cyclophosphamide Post-Transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:11

    Topics: Adolescent; Allografts; Antilymphocyte Serum; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Depletion; Male; Mycophenolic Acid; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Vidarabine

2019
Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014, Volume: 20, Issue:12

    Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents, Alkylating; Busulfan; Child; Child, Preschool; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Myeloablative Agonists; Prospective Studies; Tacrolimus; Transplantation Conditioning; Unrelated Donors; Vidarabine

2014
Alternative donor hematopoietic cell transplantation for Fanconi anemia.
    Blood, 2015, Jun-11, Volume: 125, Issue:24

    Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Child, Preschool; Cyclophosphamide; Enzyme Inhibitors; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Middle Aged; Opportunistic Infections; Survival Analysis; Tissue Donors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Young Adult

2015
Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey.
    Pediatric blood & cancer, 2016, Volume: 63, Issue:4

    Topics: Adolescent; Antilymphocyte Serum; Child; Child, Preschool; Cyclophosphamide; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Myeloablative Agonists; Tissue Donors; Transplantation Conditioning; Turkey; Vidarabine

2016
Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.
    Blood, 2017, 04-20, Volume: 129, Issue:16

    Topics: Adolescent; Adult; Antilymphocyte Serum; Bone Marrow; Busulfan; Child; Child, Preschool; Cyclophosphamide; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphocyte Depletion; Male; Myeloablative Agonists; Myelodysplastic Syndromes; Prospective Studies; Siblings; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine

2017
Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Fanconi Anemia; Female; Follow-Up Studies; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Male; Pilot Projects; Radiation; Risk Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine

2009
Better posttransplant outcome with fludarabine based conditioning in multitransfused fanconi anemia patients who underwent peripheral blood stem cell transplantation.
    Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:7

    Topics: Adolescent; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Fanconi Anemia; Female; Graft vs Host Disease; Humans; Male; Peripheral Blood Stem Cell Transplantation; Radiotherapy; Transplantation Conditioning; Treatment Outcome; Vidarabine

2009
Treatment of Fanconi anemia patients using fludarabine and low-dose TBI, followed by unrelated donor hematopoietic cell transplantation.
    Bone marrow transplantation, 2011, Volume: 46, Issue:4

    Topics: Child; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Survival Rate; Tissue Donors; Transplantation Chimera; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation

2011

Other Studies

35 other study(ies) available for fludarabine and Anemia, Fanconi

ArticleYear
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
    Journal of biomolecular screening, 2016, Volume: 21, Issue:6

    Topics: Antineoplastic Agents; DNA Damage; DNA Helicases; DNA Repair; Drug Screening Assays, Antitumor; Fanconi Anemia; High-Throughput Screening Assays; Humans; Multiprotein Complexes; Protein Interaction Maps; RecQ Helicases

2016
Fludarabine- and low-dose cyclophosphamide-based conditioning regimens provided favorable survival and engraftment for unmanipulated hematopoietic cell transplantation from unrelated donors and matched siblings in patients with Fanconi anemia: results fro
    Bone marrow transplantation, 2023, Volume: 58, Issue:1

    Topics: Cyclophosphamide; Fanconi Anemia; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Siblings; Transplantation Conditioning; Unrelated Donors; Vidarabine

2023
Human leucocyte antigen-matched related haematopoietic stem cell transplantation using low-dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia.
    British journal of haematology, 2023, Volume: 203, Issue:2

    Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Congenital Bone Marrow Failure Syndromes; Cyclophosphamide; DNA Helicases; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Antigens Class II; HLA Antigens; Humans; Male; Transplantation Conditioning

2023
Bone marrow transplant using fludarabine-based reduced intensity conditioning regimen with in vivo T cell depletion in patients with Fanconi anemia.
    Pediatric transplantation, 2021, Volume: 25, Issue:4

    Topics: Bone Marrow Transplantation; Child; Drug Therapy, Combination; Fanconi Anemia; Humans; Lymphocyte Depletion; Myeloablative Agonists; Siblings; T-Lymphocytes; Transplantation Conditioning; Vidarabine

2021
Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2017, Volume: 52, Issue:7

    Topics: 5' Untranslated Regions; 5'-Nucleotidase; Adolescent; Adult; Allografts; Child; Child, Preschool; Cyclophosphamide; Fanconi Anemia; Female; GPI-Linked Proteins; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Polymorphism, Genetic; Vidarabine

2017
[Outcomes of alternative donor allogeneic hematopoietic stem cell transplantation for Fanconi anemia: a five cases report].
    Zhonghua nei ke za zhi, 2018, Jan-01, Volume: 57, Issue:1

    Topics: Antilymphocyte Serum; Bone Marrow; Cyclophosphamide; Fanconi Anemia; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Retrospective Studies; Transplantation Conditioning; Treatment Outcome; Unrelated Donors; Vidarabine

2018
Successful hematopoietic cell transplantation in Fanconi anemia patients with renal impairment using ultra-reduced doses of cyclophosphamide and fludarabine.
    Pediatric blood & cancer, 2018, Volume: 65, Issue:12

    Topics: Cyclophosphamide; Fanconi Anemia; Female; Hematopoietic Stem Cell Transplantation; Humans; Kidney Diseases; Male; Transplantation Conditioning; Vidarabine

2018
HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014, Volume: 20, Issue:4

    Topics: Adolescent; Antigens, CD34; Child; Fanconi Anemia; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Lymphocyte Depletion; Male; Myeloablative Agonists; Prospective Studies; Survival Analysis; T-Lymphocytes; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Unrelated Donors; Vidarabine

2014
Factors affecting the outcome of related allogeneic hematopoietic cell transplantation in patients with Fanconi Anemia.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014, Volume: 20, Issue:10

    Topics: Adolescent; Carcinoma, Squamous Cell; Child; Child, Preschool; Cyclophosphamide; Cystitis; Fanconi Anemia; Female; Gamma Rays; Hematopoietic Stem Cell Transplantation; Hemorrhage; Histocompatibility Testing; Humans; Infant; Male; Myeloablative Agonists; Oropharyngeal Neoplasms; Retrospective Studies; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Vidarabine

2014
Successful hematopoietic reconstitution by unrelated donor cord blood transplantation in children with Fanconi anemia: report of 3 cases.
    Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:8

    Topics: Animals; Antilymphocyte Serum; Antineoplastic Agents, Alkylating; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Fanconi Anemia; Graft vs Host Disease; Hematopoiesis; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Male; Myeloablative Agonists; Rabbits; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2014
HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine.
    Blood, 2015, Jan-08, Volume: 125, Issue:2

    Topics: Adolescent; Child; Cyclophosphamide; Fanconi Anemia; Female; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Male; Transplantation Conditioning; Vidarabine; Young Adult

2015
[Molecular diagnosis and hematopoietic stem cell transplantation in 17 children with inherited bone marrow failure syndrome].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2015, Volume: 53, Issue:11

    Topics: Anemia, Aplastic; Anemia, Diamond-Blackfan; Bone Marrow Diseases; Bone Marrow Failure Disorders; Child; Dyskeratosis Congenita; Fanconi Anemia; Fetal Blood; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Retrospective Studies; Siblings; Survival Rate; Transplantation Conditioning; Unrelated Donors; Vidarabine

2015
Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:9

    Topics: Adolescent; Antimetabolites, Antineoplastic; Child; Cytarabine; Fanconi Anemia; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Myeloablative Agonists; Transplantation Conditioning; Treatment Outcome; Unrelated Donors; Vidarabine

2016
Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine.
    Bone marrow transplantation, 2010, Volume: 45, Issue:2

    Topics: Child, Preschool; Cyclophosphamide; Fanconi Anemia; Female; Humans; Renal Insufficiency; Stem Cell Transplantation; Transplantation, Homologous; Vidarabine

2010
Natural pregnancy and delivery after unrelated bone marrow transplantation using fludarabine-based regimen in a Fanconi anemia patient.
    International journal of hematology, 2010, Volume: 91, Issue:2

    Topics: Bone Marrow Transplantation; Child; Delivery, Obstetric; Fanconi Anemia; Female; Fertility; Humans; Myeloablative Agonists; Pregnancy; Pregnancy Outcome; Vidarabine; Young Adult

2010
Bone marrow transplantation for Fanconi anemia using fludarabine-based conditioning.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:9

    Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide; Fanconi Anemia; Graft Survival; Humans; Infant; Retrospective Studies; Transplantation Conditioning; Vidarabine; Young Adult

2011
The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012, Volume: 18, Issue:4

    Topics: Adolescent; Antilymphocyte Serum; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cystitis; Disease-Free Survival; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Male; Prospective Studies; Saudi Arabia; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Vidarabine

2012
Long-term results of non-fludarabine versus fludarabine-based stem cell transplantation without total body irradiation in Fanconi anemia patients.
    Hematology/oncology and stem cell therapy, 2011, Volume: 4, Issue:3

    Topics: Adolescent; Adult; Cause of Death; Child; Child, Preschool; Fanconi Anemia; Female; Graft Rejection; Graft vs Host Disease; Humans; Male; Middle Aged; Myeloablative Agonists; Stem Cell Transplantation; Survival Analysis; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation; Young Adult

2011
Matched sibling donor stem cell transplantation for Fanconi anemia patients with T-cell somatic mosaicism.
    Pediatric transplantation, 2012, Volume: 16, Issue:4

    Topics: Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chimerism; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Fanconi Anemia; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Infant; Male; Mosaicism; Stem Cell Transplantation; T-Lymphocytes; Transplantation Conditioning; Treatment Outcome; Vidarabine; Young Adult

2012
Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.
    Pediatric hematology and oncology, 2012, Volume: 29, Issue:6

    Topics: Adolescent; Antineoplastic Agents; Child; Combined Modality Therapy; Fanconi Anemia; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Lymphocyte Depletion; T-Lymphocytes; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2012
Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation.
    Bone marrow transplantation, 2003, Volume: 31, Issue:6

    Topics: Child; Fanconi Anemia; Female; Haploidy; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Immunotherapy, Adoptive; T-Lymphocytes; Transplantation Chimera; Transplantation Conditioning; Vidarabine

2003
Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors.
    Bone marrow transplantation, 2003, Volume: 32, Issue:7

    Topics: Adolescent; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Fanconi Anemia; Female; Graft Survival; Graft vs Host Disease; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Kinetics; Male; Siblings; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2003
Fludarabine, low-dose busulfan and antithymocyte globulin as conditioning for Fanconi anemia patients receiving bone marrow transplantation from HLA-compatible related donors.
    Bone marrow transplantation, 2004, Volume: 34, Issue:4

    Topics: Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cytomegalovirus Infections; Drug Therapy, Combination; Fanconi Anemia; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Living Donors; Male; Postoperative Complications; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2004
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Pediatric blood & cancer, 2006, May-01, Volume: 46, Issue:5

    Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Survival Rate; T-Lymphocytes; Treatment Outcome; Vidarabine

2006
Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:7

    Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antilymphocyte Serum; Busulfan; Child; Child, Preschool; Cyclophosphamide; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Myeloablative Agonists; Transplantation Conditioning; Treatment Outcome; Vidarabine

2006
Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia.
    British journal of haematology, 2006, Volume: 134, Issue:2

    Topics: Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Fanconi Anemia; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Pilot Projects; Transplantation Conditioning; Treatment Outcome; Vidarabine; Whole-Body Irradiation

2006
In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.
    International journal of hematology, 2007, Volume: 85, Issue:4

    Topics: Antimetabolites, Antineoplastic; Cells, Cultured; Chromosome Breakage; Chromosome Fragility; Cyclophosphamide; Cytarabine; Fanconi Anemia; Female; Humans; Male; Myeloablative Agonists; Stem Cell Transplantation; Transplantation Conditioning; Vidarabine

2007
Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Fanconi Anemia; Female; Graft Survival; Histocompatibility Testing; Humans; Infant; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Analysis; Transplantation Conditioning; Vidarabine

2007
CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:5

    Topics: Adolescent; Antigens, CD34; Antineoplastic Agents; Child; DNA (Cytosine-5-)-Methyltransferases; Fanconi Anemia; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; HLA Antigens; Humans; Lymphocyte Depletion; Male; Recombinant Proteins; T-Lymphocytes; Transplantation Conditioning; Vidarabine

2008
The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.
    Haematologica, 2007, Volume: 92, Issue:10

    Topics: Adolescent; Adult; Child; Child, Preschool; Fanconi Anemia; Female; Hematopoietic Stem Cell Transplantation; Humans; Italy; Male; Probability; Survival Rate; Transplantation Conditioning; Treatment Outcome; Vidarabine

2007
Successful bone marrow transplantation in a girl with Fanconi anemia and preterminal renal failure.
    Bone marrow transplantation, 2008, Volume: 42, Issue:1

    Topics: Bone Marrow Transplantation; Child, Preschool; Directed Tissue Donation; Fanconi Anemia; Female; Graft Survival; Graft vs Host Disease; Hemibody Irradiation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Mycophenolic Acid; Siblings; Transplantation Chimera; Transplantation Conditioning; Vesico-Ureteral Reflux; Vidarabine

2008
A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia.
    Bone marrow transplantation, 1997, Volume: 20, Issue:12

    Topics: Antineoplastic Agents; Child; Cyclophosphamide; Fanconi Anemia; Female; Humans; Leukemia, Myeloid; Male; Preleukemia; Remission Induction; Risk Factors; Transplantation Conditioning; Vidarabine

1997
Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts.
    British journal of haematology, 2000, Volume: 111, Issue:4

    Topics: Child, Preschool; Cyclophosphamide; Fanconi Anemia; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lymphocyte Depletion; Male; Recombinant Proteins; T-Lymphocytes; Tacrolimus; Vidarabine

2000
Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation.
    British journal of haematology, 2001, Volume: 112, Issue:2

    Topics: Adolescent; Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins; Immunosuppressive Agents; Male; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2001
Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning.
    Bone marrow transplantation, 2001, Volume: 28, Issue:1

    Topics: Antineoplastic Agents; Child, Preschool; Fanconi Anemia; Female; Fetal Blood; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Transplantation Conditioning; Vidarabine

2001